146 related articles for article (PubMed ID: 22135639)
1. Hepatitis B virus and HIV infection among patients with primary hepatocellular carcinoma in Kampala, Uganda.
Ocama P; Opio KC; Kagimu M; Seremba E; Wabinga H; Colebunders R
Afr Health Sci; 2011 Aug; 11 Suppl 1(Suppl 1):S20-3. PubMed ID: 22135639
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of hepatitis B and C and relationship to liver damage in HIV infected patients attending Joint Clinical Research Centre Clinic (JCRC), Kampala, Uganda.
Baseke J; Musenero M; Mayanja-Kizza H
Afr Health Sci; 2015 Jun; 15(2):322-7. PubMed ID: 26124775
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B status and associated factors among participants screened for simulated HIV vaccine efficacy trials in Kenya and Uganda.
Mayanja Y; Rida W; Kimani J; Ssetala A; Mpendo J; Nanvubya A; Mutua G; Anzala O; Price MA
PLoS One; 2023; 18(7):e0288604. PubMed ID: 37459311
[TBL] [Abstract][Full Text] [Related]
4. Early childhood transmission of hepatitis B prior to the first hepatitis B vaccine dose is rare among babies born to HIV-infected and non-HIV infected mothers in Gulu, Uganda.
Seremba E; Van Geertruyden JP; Ssenyonga R; Opio CK; Kaducu JM; Sempa JB; Colebunders R; Ocama P
Vaccine; 2017 May; 35(22):2937-2942. PubMed ID: 28434689
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV.
Maponga TG; Glashoff RH; Vermeulen H; Robertson B; Burmeister S; Bernon M; Omoshoro-Jones J; Ruff P; Neugut AI; Jacobson JS; Preiser W; Andersson MI
BMC Gastroenterol; 2020 Jul; 20(1):226. PubMed ID: 32660431
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B and HIV co-infection is still treated using lamivudine-only antiretroviral therapy combination in Uganda.
Ocama P; Seremba E; Apica B; Opio K
Afr Health Sci; 2015 Jun; 15(2):328-33. PubMed ID: 26124776
[TBL] [Abstract][Full Text] [Related]
7. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.
Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA
World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450
[TBL] [Abstract][Full Text] [Related]
8. Screening for hepatocellular carcinoma among adults with HIV/HBV co-infection in Zambia: a pilot study.
Riebensahm C; Chitundu H; Muula G; Chihota B; Sinkala E; Sunkutu V; Maurer MH; Dufour JF; Berzigotti A; Egger M; Bolton-Moore C; Vinikoor M; Wandeler G;
Int J Infect Dis; 2022 Mar; 116():391-396. PubMed ID: 34952210
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique.
Semá Baltazar C; Boothe M; Kellogg T; Ricardo P; Sathane I; Fazito E; Raymond HF; Temmerman M; Luchters S
BMC Public Health; 2020 Jun; 20(1):851. PubMed ID: 32493347
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection.
Ferrante ND; Lo Re V
Curr HIV/AIDS Rep; 2020 Aug; 17(4):405-414. PubMed ID: 32607773
[TBL] [Abstract][Full Text] [Related]
11. Occult hepatitis B virus infection is not associated with disease progression of chronic hepatitis C virus infection.
Cho J; Lee SS; Choi YS; Jeon Y; Chung JW; Baeg JY; Si WK; Jang ES; Kim JW; Jeong SH
World J Gastroenterol; 2016 Nov; 22(42):9427-9436. PubMed ID: 27895431
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological and clinical characteristics of hepatitis B virus in HIV-infected patients in Guangdong, China.
Huang SM; Cai WP; Hu FY; Lan Y; Liao BL; Chen YP; Tang XP
Int J STD AIDS; 2016 Sep; 27(10):890-7. PubMed ID: 26384940
[TBL] [Abstract][Full Text] [Related]
13. Immune response to the hepatitis B vaccine among HIV-infected adults in Uganda.
Seremba E; Ocama P; Ssekitoleko R; Mayanja-Kizza H; Adams SV; Orem J; Katabira E; Reynolds SJ; Nabatanzi R; Casper C; Phipps W
Vaccine; 2021 Feb; 39(8):1265-1271. PubMed ID: 33516601
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of hepatitis B in the southeast of China: a population-based study with a large sample size.
Luo Z; Xie Y; Deng M; Zhou X; Ruan B
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):695-700. PubMed ID: 21617533
[TBL] [Abstract][Full Text] [Related]
15. Hepatic transaminase and alkaline phosphatase enzyme levels in HIV/HBV co-infected and HIV mono-infected patients in Maiduguri, Nigeria.
Goni BW; Yusuph H; Mustapha SK; Sahabi MA; Gwalabe SA; Tahir A; Bakki B; Kida IM
Niger J Clin Pract; 2013; 16(4):530-4. PubMed ID: 23974753
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology, natural history and prevention of hepatitis B: implications of HIV coinfection.
McGovern BH
Antivir Ther; 2007; 12 Suppl 3():H3-13. PubMed ID: 18284178
[TBL] [Abstract][Full Text] [Related]
17. Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients.
Anggorowati N; Yano Y; Heriyanto DS; Rinonce HT; Utsumi T; Mulya DP; Subronto YW; Hayashi Y
J Med Virol; 2012 Jun; 84(6):857-65. PubMed ID: 22499006
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B and HIV coinfection in Northern Uganda: Is a decline in HBV prevalence on the horizon?
Chiesa A; Ochola E; Oreni L; Vassalini P; Rizzardini G; Galli M
PLoS One; 2020; 15(11):e0242278. PubMed ID: 33206693
[TBL] [Abstract][Full Text] [Related]
19. Field performance of the Determine HBsAg point-of-care test for diagnosis of hepatitis B virus co-infection among HIV patients in Zambia.
Chisenga CC; Musukuma K; Chilengi R; Zürcher S; Munamunungu V; Siyunda A; Ojok D; Bauer S; Wandeler G; Vinikoor M;
J Clin Virol; 2018 Jan; 98():5-7. PubMed ID: 29175231
[TBL] [Abstract][Full Text] [Related]
20. A prominent role of Hepatitis D Virus in liver cancers documented in Central Africa.
Amougou MA; Noah DN; Moundipa PF; Pineau P; Njouom R
BMC Infect Dis; 2016 Nov; 16(1):647. PubMed ID: 27821080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
